China News Service, Changchun, October 17 (Reporter Guo Jia) As the "facial value economy" continues to heat up, medical aesthetics has gradually become a "rigorous need" for some people, and the society's attention to the safety of medical aesthetics is also pushing Chinese medicine The US market has launched a new round of "technology war".

　　The 2021 Recycled Materials Prospects Forum will be held in Changchun recently.

The new technology shared by Cui Liguo, an associate researcher at the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, sparked heated discussions among participants.

It is said that this technology is disruptive to the Chinese medical beauty industry.

　　The technology shared by Cui Liguo is called "poly-L-lactic acid (PLLA) biomedical polymer material technology".

He explained that lactic acid has a "biological signal" effect. When lactic acid sends out a signal, it will activate proline hydroxylase and stimulate the regeneration of autologous collagen, which is a kind of "active regeneration". The principle of catalysis can be applied to medical aesthetics.

　　Cui Liguo said that Changchun Shengbomar Biomaterials Co., Ltd., established by the relevant team of the Changchun Institute of Applied Chemistry of the Chinese Academy of Sciences, has innovatively applied this technology to medical and aesthetic injection products, and the results have been successfully transformed.

　　"The transformation of technological achievements in biomedical polymer materials represented by the renewable material poly-L-lactic acid (PLLA) marks the beginning of China's injection medical aesthetics from the'filling era' to the'regeneration era'." Cui Liguo said.

　　At present, there are only three types of collagen renewable injection products approved for the three types of medical devices in China, and one of them is Saint-Boma's product.

With the relatively limited supply of this subdivision track, it is attracting more and more companies to join, and competition is becoming increasingly fierce.

　　It is understood that the size of China's medical cosmetology market in 2020 is about 197.5 billion yuan, and its market size is expected to reach 311.5 billion yuan by 2023.

With the growth of the people's disposable income and the continuous increase in the penetration rate of medical aesthetics consumption, the medical aesthetics market has huge growth potential and industry dividends.

　　Jin Xing, CEO of New Oxygen Technology, said that at this stage, China's medical beauty market is in a period of rapid development. With the continuous improvement of social recognition, the consumer population has expanded from mid-to-high-end consumers to mass consumers.

At the same time, more and more men also favor medical beauty.

The overall consumer group reflects the trend of popularization, younger age and gender.

　　However, due to the rise of the "appearance economy", some medical and aesthetic chaos has become an obstacle to the development of the industry. Participants believed that the problems exposed by the medical and aesthetic industry mainly include imperfect social management, shortage of professional talents, and blind worship of foreign technology.

　　"The effectiveness of any medical aesthetics product should be based on safety." Shi Bing, director of the Plastic and Aesthetic Surgery Department of the Eighth Medical Center of the PLA General Hospital, said that the independent R&D and application of China's medical aesthetics is important for promoting the development of global medical aesthetics. It is of great significance. It is hoped that all parties will actively carry out more clinical research and promote the standardized development of products.

　　Relevant experts at the meeting suggested that consumers should choose formal channels and institutions to prevent being deceived.

In addition, only when consumption is moderate, objective and rational, and vigilant, can consumption be assured and comfortable.

(over)